Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204202 · ClinicalTrials.gov registry record
PET Assessment of Acute Lung Transplant Rejection
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 28
- Enrollment target
NCT02204202 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 28 participants.
The verdict
NCT02204202 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to gain understanding of the basic responses of the lungs to inflammation and specifically if there may be a better way to detect graft inflammation using non-invasive methods as well as to determine the effectiveness of immunosuppressive treatment regimens in preventing acute rejection in lung transplant recipients.
Interventions
- DRUG [18F]FDG
- DRUG [18F]ISO-1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-02-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02204202
The ClinicalTrials.gov registry entry for NCT02204202 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which [18F]FDG is the first listed.
NCT02204202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02204202 about?
NCT02204202 is a clinical study titled "PET Assessment of Acute Lung Transplant Rejection". The purpose of this research study is to gain understanding of the basic responses of the lungs to inflammation and specifically if there may be a better way to detect graft inflammation using non-invasive methods as well as to determine the effectiveness of immunosuppressive treatment regimens in p...
What is the current status of trial NCT02204202?
This trial is currently terminated. The enrollment target is 28 participants. The study started on 2014-02. Estimated completion is 2017-02-04.
What interventions are being tested in trial NCT02204202?
The interventions under investigation include: [18F]FDG (DRUG), [18F]ISO-1 (DRUG).
Who is sponsoring clinical trial NCT02204202?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.